Provided by Tiger Trade Technology Pte. Ltd.

VanEck Pharmaceutical ETF

111.17
-0.4966-0.44%
Post-market: 111.170.00000.00%19:30 EDT
Volume:141.85K
Turnover:15.75M
Market Cap:1.00B
PE:90.08
High:111.66
Open:111.56
Low:110.63
Close:111.67
52wk High:118.00
52wk Low:85.91
Shares:9.04M
Float Shares:9.04M
Volume Ratio:0.80
T/O Rate:1.57%
Dividend:2.18
Dividend Rate:1.96%
EPS(TTM):1.23
EPS(LYR):0.7765
ROE:--
ROA:--
PB:--
PE(LYR):143.17

Loading ...

Abbvie Exec Says Plans to Start Enrolling Apogee's Zumilokibart This Year, Targets Launch in Early 2030 - Conf Call

THOMSON REUTERS
·
Sep 15

Abbvie Exec Says Tavapadon U.S. Launch Expected to Have 'Slower Burn' Due to Timing of Medicare Reimbursement - Conf Call

THOMSON REUTERS
·
Sep 15

Why One of the Last Eli Lilly Holdouts Just Upgraded the Stock to Buy

Dow Jones
·
Sep 15

Sector Update: Healthcare

MT Newswires Live
·
Sep 15

Legend Biotech Taps Novartis Veteran Zhang as CEO

Reuters
·
Sep 15

Novo Nordisk Stock (NVO) Is Falling Despite Rebrand to ‘Novo’ — Here’s Why

TIPRANKS
·
Sep 15

U.S. Stocks on the MOVE-Eli Lilly, Waystar, Sysco

Reuters
·
Sep 15

Testosterone Scripts for Women Rise, Along with Denials and Delays

Reuters
·
Sep 15

Novo Nordisk rebranding as ‘Novo,’ announces cultural reset

TIPRANKS
·
Sep 15

Berenberg Upgrades Eli Lilly and Co. to Buy From Hold, Adjusts Price Target to $1,400 From $1,220

MT Newswires Live
·
Sep 15

Lilly Gains After Berenberg Upgrades to 'buy' on Obesity Pill Momentum

Reuters
·
Sep 15

Eli Lilly : Berenberg Raises to Buy from Hold; Raises Target Price to $1,400 from $1,220

THOMSON REUTERS
·
Sep 15

RBC Capital Sticks to Their Hold Rating for Merck & Company (MRK)

TIPRANKS
·
Sep 15

RBC Capital Sticks to Their Buy Rating for Eli Lilly & Co (LLY)

TIPRANKS
·
Sep 15

Lilly Says Foundayo Has Captured over 30% of New US Patients on Oral Weight-Loss Drugs

Reuters
·
Sep 15

AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 15

NYSE Order Imbalance 99880.0 Shares on Sell Side

THOMSON REUTERS
·
Sep 15

Merck & Co Exec Says Potential 340B and Policy Evolutions Would Create Tailwinds but are not Material to the Business - Morgan Stanley Conf

THOMSON REUTERS
·
Sep 15

Merck & Co Exec Says Timing for Raising the $70 Bln Forecast is "to be Determined" Adds "It's Coming"

THOMSON REUTERS
·
Sep 15

Eli Lilly Stock (LLY) Has 45% Upside, Says Citigroup

TIPRANKS
·
Sep 15